Work

Assessing biosimilar entry in the market for biologic cancer drugs.

Year: 2025
Type: conference-abstract
Language: English
Subfield: Immunology
Open Access status: closed
OpenAlex ID: W4410812262
Cites:
Cited by: 2
Related to: 10